Domů › Nadváha › Florida › Miami
Klinické studie Nadváha v Miami, FL
23 studií pro Nadváha hledá účastníky v lokalitách v Miami a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Probíhá náborFáze 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Probíhá náborFáze 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Probíhá náborFáze 1
- Clinical Pharmacology of Miami, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Probíhá náborFáze 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Probíhá náborFáze 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Probíhá náborFáze 1
- Clinical Pharmacology of Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Probíhá náborFáze 3
- BioMed Research & Medical Center, Miami
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Probíhá náborFáze 3
- Finlay Medical Research, Miami
- Suncoast Research Group LLC, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Probíhá náborFáze 3
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Probíhá náborFáze 3
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Probíhá náborFáze 2
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Probíhá náborFáze 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Horizon Research Center, Miami
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Probíhá náborFáze 3Vítáni zdraví dobrovolníci
- ACCOMPLISH-2 Research Site, Miami
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Probíhá náborFáze 3
- PharmaDev Clinical Research Institute LLC, Miami
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Probíhá náborFáze 2
- New Horizon Research Center, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Probíhá náborFáze 3
- Optimus U Corporation, Miami
- Research Institute of South Florida, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Probíhá náborFáze 3
- Optimus U Corporation, Miami
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Probíhá náborFáze 3
- Kailera Clinical Site, Miami
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Probíhá náborFáze 3
- New Horizon Research Center, Miami
- Research Institute of South Florida, Miami
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Probíhá náborFáze 3
- ACCOMPLISH-1 Research Site, Miami
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Studie Nadváha v jiných městech
- San Antonio, TX34 studií
- Houston, TX33 studií
- Chicago, IL28 studií
- Orlando, FL27 studií
- Las Vegas, NV23 studií
- Atlanta, GA20 studií
- Dallas, TX20 studií
- Washington, DC19 studií
- New York City, NY19 studií
- Jacksonville, FL19 studií
- Austin, TX18 studií
- Havelock, NC17 studií
Další studie v Miami
- Rakovina prsu42 studií
- Rakovina (všechny typy)36 studií
- Nemalobuněčný plicní karcinom31 studií
- Rakovina prostaty27 studií
- Obesity27 studií
- Akutní myeloidní leukemie24 studií
- Rakovina vaječníků23 studií
- Metastatický karcinom23 studií
- Ulcerózní kolitida22 studií
- Mnohočetný myelom21 studií
- Alzheimerova choroba20 studií
- Rakovina plic20 studií
Zdroj: ClinicalTrials.gov, data načtena 2. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.